EUVIMEDEUVIMED entdecken
Leitlinie

The 2024 European guideline on the management of epididymo‐orchitis

Edwin D Justice, John Fricker iD, Jonathan D C Ross, Zsolt Kopa, Mihael Skerlev, Rajul Patel

Journal of the European Academy of Dermatology and Venereology · 2026-02 · 40 (2) · 166-173

DOI: 10.1111/jdv.20865 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 23.07.2025. Verfasst von Edwin D Justice und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Royal Wolverhampton NHS Trust, West Midlands, UK. Hauptthemen laut MEDLINE: Epididymitis, Orchitis, Anti-Bacterial Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The European guideline on the management of epididymo‐orchitis has been updated in 2024. This guideline offers advice on the diagnosis, investigation, treatment and follow‐up for the management of epididymo‐orchitis. For treatment of patients with a history suggestive of sexually transmitted pathogens—ceftriaxone dose increased to 1 g intramuscularly (IM) single dose alongside doxycycline. The use of dual therapy with azithromycin is no longer recommended, unless cefixime is being given as an alternative to ceftriaxone. For treatment of patients with a history including risks for both sexually transmitted and enteric pathogens—ceftriaxone IM single dose and either ofloxacin or levofloxacin is recommended. Where enteric pathogens are suspected as the likely cause, either ofloxacin or levofloxacin is recommended as monotherapy. This guideline covers a range of clinical scenarios, including rarer and non‐sexually transmitted causative agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpididymitisOrchitisAnti-Bacterial AgentsHumansMaleEuropeCeftriaxoneAzithromycin

Stichwörter der Autor:innen

Europeantibioticepididymisepidiymo‐orchitisorchitistreatment

Substanzen

Anti-Bacterial AgentsCeftriaxoneAzithromycin

Autor:innen und Institutionen

  • The Royal Wolverhampton NHS Trust, West Midlands, UK.
  • Hampshire and Isle of Wight NHS Foundation Trust, Southampton, UK.
  • University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Semmelweis University, Budapest, Hungary.
  • Department of Dermatology and Venereology, Zagreb University School of Medicine, Zagreb, Croatia.
  • University of Southampton, Southampton, UK.

ORCID-Profile: John Fricker

Zitieren

APA

Justice, E. D., Fricker, J., Ross, J. D. C., Kopa, Z., Skerlev, M., & Patel, R. (2026). The 2024 European guideline on the management of epididymo‐orchitis. Journal of the European Academy of Dermatology and Venereology, 40(2), 166-173. https://doi.org/10.1111/jdv.20865

Vancouver

Justice ED, Fricker J, Ross JDC, Kopa Z, Skerlev M, Patel R. The 2024 European guideline on the management of epididymo‐orchitis. Journal of the European Academy of Dermatology and Venereology. 2026;40(2):166-173. doi:10.1111/jdv.20865

BibTeX
@article{Justice2026,
  author = {Justice, Edwin D and Fricker, John and Ross, Jonathan D C and Kopa, Zsolt and Skerlev, Mihael and Patel, Rajul},
  title = {The 2024 European guideline on the management of epididymo‐orchitis},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2026},
  volume = {40},
  number = {2},
  pages = {166--173},
  doi = {10.1111/jdv.20865}
}
Kostenlos starten →